[VIRTUAL] A phase II study of BP1001 (liposomal Grb2 antisense oligonucleotide) in patients with hematologic malignancies.

decitabine - Generic mfg.

BP001 (omalizumab biosimilar) - BiosanaPharma

cytarabine - Generic mfg.

prexigebersen (BP1001) - Bio-Path

https://meetinglibrary.asco.org/record/191789

Maro Ohanian; Tara L. Lin; Michael Craig; Apurv Agrawal; Kathleen Halka; Ana Tari Ashizawa; Jorge E. Cortes; Gail J. Roboz

Apr 29, 2020